Literature DB >> 22491657

Kidney volume changes in patients with autosomal dominant polycystic kidney disease after renal transplantation.

Takayuki Yamamoto1, Yoshihiko Watarai, Takaaki Kobayashi, Yoshiko Matsuda, Makoto Tsujita, Takahisa Hiramitsu, Koji Nanmoku, Norihiko Goto, Akio Katayama, Yoshihiro Tominaga, Kazuharu Uchida.   

Abstract

BACKGROUND: Few studies have investigated whether the volume of native kidney and liver (when combined with polycystic disease) in patients with autosomal dominant polycystic kidney disease (ADPKD) decreases after renal transplantation.
METHODS: Changes in the volume of native kidney (bilateral: n=28; unilateral: n=5) and liver (concomitant polycystic disease: n=18) were analyzed in 33 patients with ADPKD, who underwent renal transplantation. Volumetry was retrospectively conducted using simple computed tomography scan data 6 months before transplantation, at the time of transplantation, and 1, 3, and 5 years after transplantation. Volume change was calculated on the basis of the value at the time of transplantation.
RESULTS: Mean±standard deviation values of bilateral native kidney volume were 3100±1417 (range: 756 to 6525; median: 2499) cm at the time of transplantation. Kidney volumes were significantly reduced in all but one patient after renal transplantation, decreasing by 37.7% and 40.6% at 1 and 3 years, respectively. The major proportion of the decrease was observed within the first year posttransplantation. In contrast, 16 of 18 patients showed significant increase of liver volumes after renal transplantation. The mean rates of increase were 8.6% and 21.4% at 1 and 3 years, respectively.
CONCLUSIONS: As the volume of native polycystic kidneys could be reduced after renal transplantation, resection would be unnecessary if the space for kidney graft is available in the absence of infection, bleeding, or malignancy. When ADPKD is combined with polycystic liver disease, the possibility of intolerable symptoms caused by growing liver cysts should also be taken into account.

Entities:  

Mesh:

Year:  2012        PMID: 22491657     DOI: 10.1097/TP.0b013e318246f910

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

1.  Volume regression of native polycystic kidneys after renal transplantation.

Authors:  Yeonsoon Jung; María V Irazabal; Fouad T Chebib; Peter C Harris; Patrick G Dean; Mikel Prieto; Fernando G Cosio; Ziad M El-Zoghby; Vicente E Torres
Journal:  Nephrol Dial Transplant       Date:  2015-06-04       Impact factor: 5.992

2.  Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Arlene B Chapman; Olivier Devuyst; Kai-Uwe Eckardt; Ron T Gansevoort; Tess Harris; Shigeo Horie; Bertram L Kasiske; Dwight Odland; York Pei; Ronald D Perrone; Yves Pirson; Robert W Schrier; Roser Torra; Vicente E Torres; Terry Watnick; David C Wheeler
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

Review 3.  ADPKD: clinical issues before and after renal transplantation.

Authors:  Piergiorgio Messa; Carlo Maria Alfieri; Emanuele Montanari; Mariano Ferraresso; Roberta Cerutti
Journal:  J Nephrol       Date:  2016-10-20       Impact factor: 3.902

4.  Embolization of renal arteries before transplantation in patients with polycystic kidney disease: a single institution long-term experience.

Authors:  F Petitpierre; F Cornelis; L Couzi; A S Lasserre; E Tricaud; Y Le Bras; P Merville; C Combe; J M Ferriere; N Grenier
Journal:  Eur Radiol       Date:  2015-05-17       Impact factor: 5.315

Review 5.  Current management of autosomal dominant polycystic kidney disease.

Authors:  Jacob A Akoh
Journal:  World J Nephrol       Date:  2015-09-06

Review 6.  Renal transplantation in autosomal dominant polycystic kidney disease.

Authors:  Nada Kanaan; Olivier Devuyst; Yves Pirson
Journal:  Nat Rev Nephrol       Date:  2014-06-17       Impact factor: 28.314

7.  Maximal kidney length predicts need for native nephrectomy in ADPKD patients undergoing renal transplantation.

Authors:  Octav Cristea; Daniel Yanko; Sarah Felbel; Andrew House; Alp Sener; Patrick P W Luke
Journal:  Can Urol Assoc J       Date:  2014-07       Impact factor: 1.862

8.  Kidney transplant patient with immunoglobulin A nephropathy subsequently diagnosed as concurrent autosomal dominant polycystic kidney disease during 17-year follow-up.

Authors:  Joichi Usui; Hirayasu Kai; Shuzo Kaneko; Mayumi Takahashi-Kobayashi; Masahiro Hagiwara; Kazuhiro Takahashi; Tatsuya Oda; Kunihiro Yamagata
Journal:  CEN Case Rep       Date:  2019-12-02

9.  Native Nephrectomy in Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease.

Authors:  Fouad T Chebib; Mikel Prieto; Yeonsoon Jung; Maria V Irazabal; Walter K Kremers; Patrick G Dean; David J Rea; Fernando G Cosio; Vicente E Torres; Ziad M El-Zoghby
Journal:  Transplant Direct       Date:  2015-11-18

10.  Simultaneous Native Nephrectomy and Kidney Transplantation in Patients With Autosomal Dominant Polycystic Kidney Disease.

Authors:  Massimiliano Veroux; Domenico Zerbo; Giusi Basile; Cecilia Gozzo; Nunziata Sinagra; Alessia Giaquinta; Angelo Sanfiorenzo; Pierfrancesco Veroux
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.